| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 131, 533-535, Copyright © 1992 by Endocrine Society
ARTICLES |
NL Ostrowski, SJ Lolait, DJ Bradley, AM O'Carroll, MJ Brownstein and WS Young 3d
Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, MD 20892.
The hepatic, vascular-type (V1aR) and the renal, antidiuretic-type (V2R) vasopressin receptor cDNAs were recently cloned from rat liver and kidney libraries, respectively. DNA fragments containing the region encoding the putative 5/6 transmembrane loops of these receptors were subcloned, separately, into RNA polymerase promoter-containing vectors from which 35S-labeled sense and antisense riboprobes were synthesized. In situ hybridization histochemistry showed high levels of V1aR transcripts in the liver and the renal medulla among the vascular bundles. Sparser labeling was found in the renal cortex, but there were no grains over the glomeruli. V1aR mRNA was detected in many brain areas, including the hippocampal formation, central amygdala, dorsolateral septum, lateral hypothalamus, suprachiasmatic, ventromedial, dorsomedial, and arcuate nuclei of the hypothalamus, nucleus of the solitary tract, cerebellum, spinal nucleus of the trigeminal tract, reticular formation, inferior olivary nucleus, and choroid plexus. Rare labeled cells were seen along the periphery of the posterior pituitary. V2R transcripts were not detected in the liver or brain, but were present in high amounts in the inner and outer renal medulla, primarily associated with collecting ducts. Sparser labeling was found in the renal cortex, and no grains were seen over the glomeruli. These data confirm the expression of the V1a vasopressin receptor in liver and brain and demonstrate that kidney expresses mRNAs encoding V1a and V2 vasopressin receptors.
This article has been cited by other articles:
![]() |
R. A. Fenton, L. Brond, S. Nielsen, and J. Praetorius Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney Am J Physiol Renal Physiol, September 1, 2007; 293(3): F748 - F760. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. O'Donnell, V. Duong, J. Suvatne, S. Foroutan, and D. M. Johnson Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent Am J Physiol Cell Physiol, August 1, 2005; 289(2): C283 - C292. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mutsuga, T. Shahar, J. G. Verbalis, C. C. Xiang, M. J. Brownstein, and H. Gainer Regulation of Gene Expression in Magnocellular Neurons in Rat Supraoptic Nucleus during Sustained Hypoosmolality Endocrinology, March 1, 2005; 146(3): 1254 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Koukoulas, J. Risvanis, R. Douglas-Denton, L. M. Burrell, K. M. Moritz, and E. M. Wintour Vasopressin Receptor Expression in the Placenta Biol Reprod, August 1, 2003; 69(2): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Orcel, V. A. Tobin, G. Alonso, and A. Rabie Immunocytochemical Localization of Vasopressin V1a Receptors in the Rat Pituitary Gonadotropes Endocrinology, November 1, 2002; 143(11): 4385 - 4388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, I. Morimoto, Y. Tanaka, N. Yanagihara, and S. Eto The Mutual Regulation of Arginine-Vasopressin and PTHrP Secretion in Dissociated Supraoptic Neurons Endocrinology, April 1, 2002; 143(4): 1521 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calmont, K. Reichwald, P. Ronco, and J. Rossert Identification of a Short cis-Acting Element in the Human Vasopressin Type 2 Receptor Gene Which Confers High-Level Expression of a Reporter Gene Specifically in Collecting Duct Cells Mol. Endocrinol., October 1, 2000; 14(10): 1682 - 1695. [Abstract] [Full Text] |
||||
![]() |
C. A. Ecelbarger, G.-H. Kim, J. Terris, S. Masilamani, C. Mitchell, I. Reyes, J. G. Verbalis, and M. A. Knepper Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney Am J Physiol Renal Physiol, July 1, 2000; 279(1): F46 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stribley and C. S. Carter Developmental exposure to vasopressin increases aggression in adult prairie voles PNAS, October 26, 1999; 96(22): 12601 - 12604. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen and Q. J. Pittman Vasopressin and Amastatin Induce V1-Receptor-Mediated Suppression of Excitatory Transmission in the Rat Parabrachial Nucleus J Neurophysiol, October 1, 1999; 82(4): 1689 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. KNEPPER, G.-H. KIM, P. FERNÁNDEZ-LLAMA, and C. A. ECELBARGER Regulation of Thick Ascending Limb Transport by Vasopressin J. Am. Soc. Nephrol., March 1, 1999; 10(3): 628 - 634. [Full Text] |
||||
![]() |
M. Burnatowska-Hledin, I. B. Lazdins, L. Listenberger, P. Zhao, A. Sharangpani, V. Folta, and B. Card VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule Am J Physiol Renal Physiol, February 1, 1999; 276(2): F199 - F209. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vaccari, S. J. Lolait, and N. L. Ostrowski Comparative Distribution of Vasopressin V1b and Oxytocin Receptor Messenger Ribonucleic Acids in Brain Endocrinology, December 1, 1998; 139(12): 5015 - 5033. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurbin, L. Boissin-Agasse, H. Orcel, A. Rabie, N. Joux, M. G. Desarmenien, P. Richard, and F. C. Moos The V1a and V1b, But Not V2, Vasopressin Receptor Genes Are Expressed in the Supraoptic Nucleus of the Rat Hypothalamus, and the Transcripts Are Essentially Colocalized in the Vasopressinergic Magnocellular Neurons Endocrinology, November 1, 1998; 139(11): 4701 - 4707. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Windle, N. Shanks, S. L. Lightman, and C. D. Ingram Central Oxytocin Administration Reduces Stress-Induced Corticosterone Release and Anxiety Behavior in Rats Endocrinology, July 1, 1997; 138(7): 2829 - 2834. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Gonzalez, V. L. M. Herrera, and N. Ruiz-Opazo Renal Immunocytochemical Distribution and Pharmacological Properties of the Dual Angiotensin II/AVP Receptor Hypertension, April 1, 1997; 29(4): 957 - 961. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |